Stimulus-responsive hybrid nanoparticles based on multiple lipids for the co-delivery of doxorubicin and Sphk2-siRNA and breast cancer therapy

Cai, 2020, pH sensitive doxorubicin-loaded nanoparticle based on Radix pseudostellariae protein-polysaccharide conjugate and its improvement on HepG2 cellular uptake of doxorubicin, Food Chem. Toxicol., 136, 10.1016/j.fct.2019.111099 Cengiz, 2015, A comparative study on the therapeutic effects of silymarin and silymarin-loaded solid lipid nanoparticles on D-GaIN/TNF-alpha-induced liver damage in Balb/c mice, Food Chem. Toxicol., 77, 93, 10.1016/j.fct.2014.12.011 Cullis, 2017, Lipid nanoparticle systems for enabling gene therapies, Mol. Ther., 25, 1467, 10.1016/j.ymthe.2017.03.013 Cullis, 1986, Lipid polymorphism and the roles of lipids in membranes, Chem. Phys. Lipids, 40, 127, 10.1016/0009-3084(86)90067-8 de Lazaro, 2021, Obstacles and opportunities in a forward vision for cancer nanomedicine, Nat. Mater., 20, 1469, 10.1038/s41563-021-01047-7 Dong, 2015, Therapeutic potential of targeted multifunctional nanocomplex co-delivery of siRNA and low-dose doxorubicin in breast cancer, Cancer Lett., 359, 178, 10.1016/j.canlet.2015.01.011 Gao, 2011, Ablation of sphingosine kinase-2 inhibits tumor cell proliferation and migration, Mol. Cancer Res., 9, 1509, 10.1158/1541-7786.MCR-11-0336 Gao, 2019, pH/Redox dual-responsive polyplex with effective endosomal escape for codelivery of siRNA and doxorubicin against drug-resistant cancer cells, ACS Appl. Mater. Interfaces, 11, 16296, 10.1021/acsami.9b02016 Gotwals, 2017, Prospects for combining targeted and conventional cancer therapy with immunotherapy, Nat. Rev. Cancer, 17, 286, 10.1038/nrc.2017.17 Handa, 2021, Recent advances in lipid-engineered multifunctional nanophytomedicines for cancer targeting, J. Contr. Release, 340, 48, 10.1016/j.jconrel.2021.10.025 Harbeck, 2017, Breast cancer, Lancet, 389, 1134, 10.1016/S0140-6736(16)31891-8 He, 2018, Lipid-based liquid crystalline nanoparticles facilitate cytosolic delivery of siRNA via structural transformation, Nano Lett., 18, 2411, 10.1021/acs.nanolett.7b05430 Hui, 2019, Role of nanoparticle mechanical properties in cancer drug delivery, ACS Nano, 13, 7410, 10.1021/acsnano.9b03924 Hutchinson, 2010, Breast cancer: challenges, controversies, breakthroughs, Nat. Rev. Clin. Oncol., 7, 669, 10.1038/nrclinonc.2010.192 Jing, 2021, Alendronate-decorated nanoparticles as bone-targeted alendronate carriers for potential osteoporosis treatment, ACS Appl. Bio Mater., 4, 4907, 10.1021/acsabm.1c00199 Kajimoto, 2013, Ongoing activation of sphingosine 1-phosphate receptors mediates maturation of exosomal multivesicular endosomes, Nat. Commun., 4, 2712, 10.1038/ncomms3712 Kemp, 2016, Combo" nanomedicine: Co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy, Adv. Drug Deliv. Rev., 98, 3, 10.1016/j.addr.2015.10.019 Khan, 2012, Advanced materials for co-delivery of drugs and genes in cancer therapy, Adv Healthc Mater, 1, 373, 10.1002/adhm.201200109 Kosaka, 2013, Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis, J. Biol. Chem., 288, 10849, 10.1074/jbc.M112.446831 Li, 2018, Co-delivery of drugs and genes using polymeric nanoparticles for synergistic cancer therapeutic effects, Adv Healthc Mater, 7, 10.1002/adhm.201700886 Liang, 2018, Sphk2 RNAi nanoparticles suppress tumor growth via downregulating cancer cell derived exosomal microRNA, J. Contr. Release, 286, 348, 10.1016/j.jconrel.2018.07.039 Liang, 2020, Metastatic heterogeneity of breast cancer: molecular mechanism and potential therapeutic targets, Semin. Cancer Biol., 60, 14, 10.1016/j.semcancer.2019.08.012 Liu, 2018, Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy, Acta Biomater., 66, 310, 10.1016/j.actbio.2017.11.010 Shi, 2021, SphK2/S1P promotes metastasis of triple-negative breast cancer through the PAK1/LIMK1/cofilin1 signaling pathway, Front. Mol. Biosci., 8, 10.3389/fmolb.2021.598218 Siegel, 2021, Cancer statistics, 2021, CA A Cancer J. Clin., 71, 7, 10.3322/caac.21654 Vaughan, 2020, Cancer-targeting nanoparticles for combinatorial nucleic acid delivery, Adv. Mater., 32, 10.1002/adma.201901081 Vijay, 2018, Low-dose doxorubicin with carotenoids selectively alters redox status and upregulates oxidative stress-mediated apoptosis in breast cancer cells, Food Chem. Toxicol., 118, 675, 10.1016/j.fct.2018.06.027 Wang, 2020, Gene/paclitaxel co-delivering nanocarriers prepared by framework-induced self-assembly for the inhibition of highly drug-resistant tumors, Acta Biomater., 103, 247, 10.1016/j.actbio.2019.12.015 Wang, 2019, Regulation of Ca(2+) signaling for drug-resistant breast cancer therapy with mesoporous silica nanocapsule encapsulated doxorubicin/siRNA cocktail, ACS Nano, 13, 274, 10.1021/acsnano.8b05639 Wei, 2017, Thermosensitive liposomal codelivery of HSA-paclitaxel and HSA-ellagic acid complexes for enhanced drug perfusion and efficacy against pancreatic cancer, ACS Appl. Mater. Interfaces, 9, 25138, 10.1021/acsami.7b07132 Yan, 2017, Positively charged combinatory drug delivery systems against multi-drug-resistant breast cancer: beyond the drug combination, ACS Appl. Mater. Interfaces, 9, 6804, 10.1021/acsami.6b14244 Yuan, 2021, Tumor-targeting pH/redox dual-responsive nanosystem epigenetically reverses cancer drug resistance by co-delivering doxorubicin and GCN5 siRNA, Acta Biomater., 135, 556, 10.1016/j.actbio.2021.09.002 Zhao, 2015, Codelivery of doxorubicin and curcumin with lipid nanoparticles results in improved efficacy of chemotherapy in liver cancer, Int. J. Nanomed., 10, 257